Adrenal suppression and Cushing's syndrome secondary to an interaction between ritonavir and fluticasone: a review of the literature
- PMID:18459946
- DOI: 10.1111/j.1468-1293.2008.00579.x
Adrenal suppression and Cushing's syndrome secondary to an interaction between ritonavir and fluticasone: a review of the literature
Abstract
Objective: The purpose of this article is to provide a systematic overview of the literature on adrenal suppression and Cushing's syndrome secondary to an interaction between inhaled/intranasal fluticasone and ritonavir. The clinical presentation, diagnosis and management will be discussed.
Methods: A literature search using Medline and EMBASE and a search of abstracts of the three previous years of major HIV-related conferences were carried out.
Results: There were 25 cases (15 adult and 10 paediatric) of significant adrenal suppression secondary to an interaction between ritonavir and inhaled fluticasone, and three cases involving ritonavir and intranasal fluticasone. Cases with other steroids were not reported; however, there were cases of adrenal suppression with itraconazole [also a potent cytochrome p (CYP) 3A4 inhibitor] and inhaled budesonide. Clinicians need to differentiate between antiretroviral-induced lipodystrophy syndrome and iatrogenic Cushing's syndrome secondary to glucocorticoid use. Long-term fluticasone and ritonavir should be avoided. If ritonavir is required, another inhaled steroid such as low-dose budesonide or beclomethasone can be used cautiously. Upon discontinuation of inhaled corticosteroids, close monitoring for symptoms of adrenal insufficiency is warranted. The need for steroid replacement therapy at physiological doses should be assessed.
Conclusions: The combination of ritonavir and fluticasone should be avoided. Budesonide, beclomethasone, triamcinolone and flunisolide appear to be safer options.
Similar articles
- Iatrogenic Cushing's syndrome in HIV-infected patients receiving ritonavir and inhaled fluticasone: description of 4 new cases and review of the literature.Valin N, De Castro N, Garrait V, Bergeron A, Bouche C, Molina JM.Valin N, et al.J Int Assoc Physicians AIDS Care (Chic). 2009 Mar-Apr;8(2):113-21. doi: 10.1177/1545109709332019. Epub 2009 Mar 6.J Int Assoc Physicians AIDS Care (Chic). 2009.PMID:19270151Review.
- Inhaled fluticasone causes iatrogenic cushing's syndrome in patients treated with Ritonavir.Mahlab-Guri K, Asher I, Gradstein S, Zung A, Radian-Sade S, Elbirt D, Sthoeger Z.Mahlab-Guri K, et al.J Asthma. 2011 Oct;48(8):860-3. doi: 10.3109/02770903.2011.606580. Epub 2011 Aug 22.J Asthma. 2011.PMID:21854345
- Cushing syndrome with secondary adrenal insufficiency from concomitant therapy with ritonavir and fluticasone.Johnson SR, Marion AA, Vrchoticky T, Emmanuel PJ, Lujan-Zilbermann J.Johnson SR, et al.J Pediatr. 2006 Mar;148(3):386-8. doi: 10.1016/j.jpeds.2005.11.034.J Pediatr. 2006.PMID:16615973
- Ritonavir-fluticasone interaction causing Cushing syndrome in HIV-infected children and adolescents.Arrington-Sanders R, Hutton N, Siberry GK.Arrington-Sanders R, et al.Pediatr Infect Dis J. 2006 Nov;25(11):1044-8. doi: 10.1097/01.inf.0000242929.95258.69.Pediatr Infect Dis J. 2006.PMID:17072128
- Iatrogenic Cushing's syndrome in a adolescent with AIDSs on ritonavir and inhaled fluticasone. Case report and literature review.Pessanha TM, Campos JM, Barros AC, Pone MV, Garrido JR, Pone SM.Pessanha TM, et al.AIDS. 2007 Feb 19;21(4):529-32. doi: 10.1097/QAD.0b013e328013d9c7.AIDS. 2007.PMID:17301576Review.No abstract available.
Cited by
- Paying more than lip service to an oral lesion: a case of plasmablastic lymphoma.Moayedi Y, Venos ES, Ghaffar H, Gough KA, Hicks LK.Moayedi Y, et al.BMJ Case Rep. 2012 Jul 13;2012:bcr2012006452. doi: 10.1136/bcr-2012-006452.BMJ Case Rep. 2012.PMID:22802569Free PMC article.
- Iatrogenic Cushing's Syndrome Following Intra-Articular Triamcinolone Injection in an HIV-Infected Patient on Cobicistat Presenting as a Pulmonary Embolism: Case Report and Literature Review.Alidoost M, Conte GA, Agarwal K, Carson MP, Lann D, Marchesani D.Alidoost M, et al.Int Med Case Rep J. 2020 Jun 9;13:229-235. doi: 10.2147/IMCRJ.S254461. eCollection 2020.Int Med Case Rep J. 2020.PMID:32607001Free PMC article.
- COPD in People with HIV: Epidemiology, Pathogenesis, Management, and Prevention Strategies.Byanova KL, Abelman R, North CM, Christenson SA, Huang L.Byanova KL, et al.Int J Chron Obstruct Pulmon Dis. 2023 Nov 29;18:2795-2817. doi: 10.2147/COPD.S388142. eCollection 2023.Int J Chron Obstruct Pulmon Dis. 2023.PMID:38050482Free PMC article.Review.
- The risks of overlooking the diagnosis of secreting pituitary adenomas.Brue T, Castinetti F.Brue T, et al.Orphanet J Rare Dis. 2016 Oct 6;11(1):135. doi: 10.1186/s13023-016-0516-x.Orphanet J Rare Dis. 2016.PMID:27716353Free PMC article.Review.
- Pharmacokinetic enhancers (cobicistat/ritonavir) and the potential for drug-drug interactions.Hollywood P, MacCann R, Lorigan D, de Barra E, McConkey S.Hollywood P, et al.Ir J Med Sci. 2020 May;189(2):693-699. doi: 10.1007/s11845-019-02125-1. Epub 2019 Nov 18.Ir J Med Sci. 2020.PMID:31735989
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Medical